Comparing Dexmedetomidine With Bupivacaine Versus Bupivacaine Alone for Caudal Block in Supra - Umbilical Surgeries

Phase 2

Completed

• Conditions: Anesthesia
• Interventions: Drug: Dexmedetomidine; Drug: Bupivacaine

• Registration Number: NCT03307590
• Lead Sponsor: Cairo University

Brief Summary

dexmedetomidine is an alpha 2 adrenergic receptor agonist that is given either systemically or combined to local anesthetics during regional blocks. Investigators studied the combination of dexmedetomedine/bupivacaine versus bupivacaine alone for caudal blockage in pediatric patients undergoing supra - umbilical surgeries.

Detailed Description

Dexmedetomidine was combined to bupivavaine and administered via caudal route to be compared to caudal bupivavaine alone for analgesia following upper trunk surgery

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2017-08-20
• Study Start: 2017-10-01
• Study First Submitted QC: 2017-10-06
• Study First Posted: 2017-10-11
• Primary Completion: 2017-12-30
• Study Completion: 2017-12-30
• Status Verified: 2018-07
• Last Update Submitted: 2018-07-16
• Last Update Posted: 2018-07-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

• supra - umbilical surgeries

Read More

Exclusion Criteria

• allergy to the drug or coagulopathy

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
D group	Dexmedetomidine	Dexmedetomidine with bupivacaine group Caudal dexmedetomidine 1.5 microgram/kg with bupivavaine (0.25%) 1.25 ml/kg were administered
B group	Bupivacaine	Bupivacaine only group Caudal bupivavaine (0.25%) 1.25 ml/kg without dexmedetomidine was administered

Primary Outcome Measures

Name	Time	Method
Pain relief	6 months study	CHEOPS scale value

Trial Locations

Locations (1)

Cairo University; 🇪🇬 Cairo, Egypt